Business Wire, Compelo Ltd., and citybizlist note Lowenstein Sandler as legal counsel to Crown Laboratories, Inc. and Hildred Capital Partners, LLC in Crown's acquisition of Bellus Medical, which will become the new Aesthetics Division of Crown Laboratories. (Lowenstein deal team led by Sam E. Khan and Herschel S. Weinstein.)

The Global Legal Chronicle notes Lowenstein Sandler's representation of Regulatory Professionals, Inc. (RPI) in its acquisition by Premier Research. The write-up lists the Lowenstein team: Steven E. Siesser, Lowell A. Citron, Brooke A. Gillar, Lesley P. Adamo, Eric Jesse, Alexander Brooks, Sophia Mokotoff, Megan Monson, Matthew A. Nemeth, and Sami Najib. View Lowenstein’s news announcement about this transaction.

CNBC highlights Intapp’s acquisition by DealCloud. Lowenstein was counsel to DealCloud for this transaction. View Lowenstein’s news announcement about this deal.

The PE Hub Network, Cision PR Newswire, and FierceBiotech note Lowenstein Sandler as counsel to Regulatory Professionals, Inc. (RPI) in its acquisition by Premier Research. View Lowenstein’s news announcement about this transaction.

The PE Hub Network and Mergers & Acquisitions note Lowenstein Sandler as counsel to NexPhase Capital, LP in its equity stake investment in Brandt Information Services, LLC.

The National Law Journal, Bloomberg Law – Big Law Business, The American Lawyer, the ABA Journal, Law360, the Sun Sentinel, the Houston Business Journal, The Am Law Litigation Daily, Adam Smith, Esq., and LawPundit spotlight the firm’s call (co-authored by Gary M. Wingens and Brad Karp of Paul Weiss and published in The New York Times) for the Trump administration to develop an immediate plan for reunifying over 2,300 children separated from their parents upon entering the United States. The American Lawyer offers a thorough profile of how the Op-Ed came about, from thought process through drafting and execution, with Wingens quoted regarding Lowenstein’s involvement: “We believe this kind of stance is consistent with who we are…It’s who we’ve always been.” Media coverage notes the support of 34 law firms nationwide. (subscription required to access certain articles)

Above the Law, Law360, and the New Jersey Law Journal note the firm’s updated associate compensation structure. Above the Law provides a visual breakdown of bonuses for the law school graduating classes of 2010-2017 and also notes the joint Op-Ed coauthored by Gary M. Wingens and Paul Weiss’s Brad Karp, published in The New York Times, which calls on the Trump administration to abide by the rule of law regarding asylum seekers crossing the U.S. border. (subscription required to access certain articles)

4-traders.com and StreetInsider.com note Lowenstein Sandler as legal co-counsel with Gracin & Marlow, LLP to Aravive Biologics, Inc. in connection with its merger with a wholly owned subsidiary of Versartis, Inc. in an all-stock transaction. (Lowenstein deal team: Alan Wovsaniker and Andrew E. Graw.)

The PE Hub Network notes Lowenstein Sandler as legal counsel to Fenway Partners and affiliated investors in those entities' acquisition of Iconic Group.

Reorg Research, Chemical Engineering, and Textile World highlight Lowenstein as the legal advisor to Indorama Ventures Public Company Limited in its joint venture acquisition of M&G Chemicals’s Corpus Christi, Texas-based PTA-PET plant. Lowenstein is also listed as Indorama’s legal advisor in its acquisition of M&G Polimeros Brazil S.A., the largest PET facility in Brazil, by Textile World, Plastic News Europe, and Plastics in Packaging. (subscription required to access Reorg Research article)

Construction Business Owner highlights Lowenstein’s representation of Foley, Inc. in its acquisition of Ransome CAT.

Gary M. Wingens and Joseph J.Palermo are quoted in Bloomberg Law – Big Law Business about Joe’s joining Lowenstein as COO and, more broadly, about the growing importance of the COO role in law firms’ strategic growth and direction. Joe’s arrival at the firm was also covered in LawFuel.

Bloomberg View cites a Forbes Tech article by Ed Zimmerman, Peter Ehrenberg, and Valeska Pederson Hintz on SEC Rule 701 in its discussion of robot funds and bank regulation.

John D. Hogoboom comments on early 2015 market dynamics in The Deal Pipeline.

John D. Hogoboom comments on the recent surge in life science offerings in The DealFlow Report.

John D. Hogoboom comments on the 2015 capital markets outlook for small-cap companies in The DealFlow Report.

John D. Hogoboom comments on the PIPE market in The Daily Deal.

John D. Hogoboom discusses the rationale for anti-shorting covenants in PIPE investments in The Deal Pipeline.

John D. Hogoboom comments in The Deal Pipeline on the current environment for life sciences IPOs.

John D. Hogoboom comments in The Deal Pipeline on novel investor litigation claiming warrant adjustment.

John D. Hogoboom is quoted in The Deal Pipeline in connection with dispute between Hudson Bay Capital Management LP and Worlds Inc. over the patent monetization company's refusal to lower the price of warrants issued last year in a private placement of convertible debt.

John D. Hogoboom comments on the current state of the market for life science IPOs in The Deal Pipeline's DealFlow Report.

In The Deal Pipeline, John D. Hogoboom comments on market dynamics affecting offerings by life science companies.

Brooke A. Gillar has been named among The M&A Advisor's "40 Under 40" in the Legal Advisor category. The M&A Advisor recognizes professionals under the age of 40 for their accomplishments and expertise in M&A, financing, and turnarounds.